Efficacy of anti-GD2 antibody immunotherapy with filgrastim and teceleukin versus standard treatment with sargramostim, aldesleukin and isotretinoin in children with high-risk neuroblastoma.
Saved in:
| Title: | Efficacy of anti-GD2 antibody immunotherapy with filgrastim and teceleukin versus standard treatment with sargramostim, aldesleukin and isotretinoin in children with high-risk neuroblastoma. |
|---|---|
| Authors: | Nitani C; Department of Pediatric Hematology and Oncology, Osaka City General Hospital, 2-13-22 Miyakojima-Hondori, Miyakojima-Ku, Osaka, 534-0021, Japan. c-tanaka@med.osakacity-hp.or.jp., Hara J; Department of Pediatric Hematology and Oncology, Osaka City General Hospital, 2-13-22 Miyakojima-Hondori, Miyakojima-Ku, Osaka, 534-0021, Japan., Kawamoto H; Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan., Taguchi T; Pediatric Surgery, Kyushu University Hospital, Fukuoka, Japan., Yuza Y; Department of Hematology and Oncology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan., Karakawa S; Department of Pediatrics, Hiroshima University Hospital, Hiroshima, Japan., Matsumoto K; Children Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Kimura T; Laboratory of Clinical Pharmacology, Faculty of Pharmacy, Juntendo University, Tokyo, Japan., Yoshimura K; Department of Biostatistics, Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan., Yoshimura K; Department of Clinical Immuno-Oncology, Clinical Research Institute of Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Hamada A; Division of Molecular Pharmacology, National Cancer Center Research Institute, Tokyo, Japan. |
| Source: | International journal of clinical oncology [Int J Clin Oncol] 2026 Jul 23. Date of Electronic Publication: 2026 Jul 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42490004 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy of anti-GD2 antibody immunotherapy with filgrastim and teceleukin versus standard treatment with sargramostim, aldesleukin and isotretinoin in children with high-risk neuroblastoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nitani+C%22">Nitani C</searchLink>; Department of Pediatric Hematology and Oncology, Osaka City General Hospital, 2-13-22 Miyakojima-Hondori, Miyakojima-Ku, Osaka, 534-0021, Japan. c-tanaka@med.osakacity-hp.or.jp.<br /><searchLink fieldCode="AU" term="%22Hara+J%22">Hara J</searchLink>; Department of Pediatric Hematology and Oncology, Osaka City General Hospital, 2-13-22 Miyakojima-Hondori, Miyakojima-Ku, Osaka, 534-0021, Japan.<br /><searchLink fieldCode="AU" term="%22Kawamoto+H%22">Kawamoto H</searchLink>; Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Taguchi+T%22">Taguchi T</searchLink>; Pediatric Surgery, Kyushu University Hospital, Fukuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Yuza+Y%22">Yuza Y</searchLink>; Department of Hematology and Oncology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Karakawa+S%22">Karakawa S</searchLink>; Department of Pediatrics, Hiroshima University Hospital, Hiroshima, Japan.<br /><searchLink fieldCode="AU" term="%22Matsumoto+K%22">Matsumoto K</searchLink>; Children Cancer Center, National Center for Child Health and Development, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kimura+T%22">Kimura T</searchLink>; Laboratory of Clinical Pharmacology, Faculty of Pharmacy, Juntendo University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshimura+K%22">Yoshimura K</searchLink>; Department of Biostatistics, Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshimura+K%22">Yoshimura K</searchLink>; Department of Clinical Immuno-Oncology, Clinical Research Institute of Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hamada+A%22">Hamada A</searchLink>; Division of Molecular Pharmacology, National Cancer Center Research Institute, Tokyo, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229616295%22">International journal of clinical oncology</searchLink> [Int J Clin Oncol] 2026 Jul 23. <i>Date of Electronic Publication: </i>2026 Jul 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+Tokyo%22">Springer-Verlag Tokyo </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>9616295 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1437-7772 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213419625%22">13419625 </searchLink><i>NLM ISO Abbreviation: </i>Int J Clin Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42490004 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10147-026-03142-8 Languages: – Code: eng Text: English Titles: – TitleFull: Efficacy of anti-GD2 antibody immunotherapy with filgrastim and teceleukin versus standard treatment with sargramostim, aldesleukin and isotretinoin in children with high-risk neuroblastoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nitani C – PersonEntity: Name: NameFull: Hara J – PersonEntity: Name: NameFull: Kawamoto H – PersonEntity: Name: NameFull: Taguchi T – PersonEntity: Name: NameFull: Yuza Y – PersonEntity: Name: NameFull: Karakawa S – PersonEntity: Name: NameFull: Matsumoto K – PersonEntity: Name: NameFull: Kimura T – PersonEntity: Name: NameFull: Yoshimura K – PersonEntity: Name: NameFull: Yoshimura K – PersonEntity: Name: NameFull: Hamada A IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 07 Text: 2026 Jul 23 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1437-7772 Titles: – TitleFull: International journal of clinical oncology Type: main |
| ResultId | 1 |
